FIELD: pharmaceuticals.
SUBSTANCE: invention relates to a sulfonamide of formula (A), a conjugate containing a sulfonamide of formula (I) and an active pharmaceutical ingredient; a method of obtaining the conjugate; a pharmaceutical composition containing a conjugate for use as a medicinal product for treating a disease selected from the group consisting of gestational diabetes mellitus, type 1 diabetes mellitus, type 2 diabetes mellitus and hyperglycemia, and/or for lowering blood glucose levels.
EFFECT: obtaining a binder for peptides.
13 cl, 2 dwg, 3 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INSULIN CONJUGATES | 2019 |
|
RU2809189C2 |
| SULFONAMIDE DERIVATIVE AND MEDICINAL USE THEREOF | 2014 |
|
RU2667520C9 |
| ORTHO-SUBSTITUTED DERIVATIVES OF BENZOIC ACID, METHOD AND INTERMEDIATE COMPOUNDS FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND USING | 2003 |
|
RU2288912C2 |
| AMINOTETRALINE DERIVATIVES CONTAINING THEIR PHARMACEUTICAL COMPOSITIONS AND USING THEM IN THERAPY | 2010 |
|
RU2546649C2 |
| PPAR-SUPPORTING COMPOUNDS FOR TREATING METABOLIC DISEASES | 2014 |
|
RU2687490C2 |
| SUBSTITUTED IMIDAZOPYRIDINYL-AMINO-PYRIDINE COMPOUNDS, USEFUL FOR TREATMENT OF CANCER | 2010 |
|
RU2619463C2 |
| THIAZOLIDINEDIONE SALTS WITH REDUCED AFFINITY TO PPAR FOR TREATMENT OF METABOLIC DISORDERS | 2010 |
|
RU2564661C2 |
| NEW METHOD FOR SYNTHESIS OF THIAZOLIDINEDIONE COMPOUNDS | 2011 |
|
RU2593370C2 |
| HETEROCYCLIC COMPOUND | 2017 |
|
RU2748693C2 |
| PYRAZOLO[1,5-a]PYRIMIDINE AND THIENO[3,2-b]PYRIMIDINE DERIVATIVES AS MODULATORS OF IRAK-4 | 2011 |
|
RU2604062C2 |
